First trimester combined screening study
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study offers a combined screening test for pregnant women in their first trimester. It helps check for potential health issues early in pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are in the first trimester of pregnancy (between 11 and 13 weeks).
- You have signed a consent form to participate in the study and agree to how your personal data is used.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood samples and routine pregnancy data to improve early detection of preeclampsia (a serious pregnancy complication). It aims to build a biobank for future research, and you can participate if you are in your first trimester with a single baby.
This trial studies whether extra screening in the first trimester for preeclampsia (dangerous blood pressure problems in pregnancy) can reduce health problems for both the mother and baby. You may be offered a screening plan that helps identify risk earlier so care can be adjusted.
This study aims to prevent preeclampsia, a serious pregnancy condition that can cause high blood pressure and other complications. Researchers will test a screening and prevention approach offered to pregnant women early in their first trimester to see if it helps reduce the risk.
This study is testing a new way to find out early in pregnancy if you might be at risk for stillbirth. If you join, researchers will follow you through delivery to see if the screening tool helps improve outcomes.
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
This study is screening first-trimester pregnant women for infections of the lower genital tract, so they can be treated early and potentially avoid pregnancy complications.
Hear when a new Preeclampsia (PE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.